[{"id":"d710738e-a173-4d1b-82da-c2c6cf5f1bd9","acronym":"","url":"https://clinicaltrials.gov/study/NCT02598895","created_at":"2021-01-18T12:36:58.377Z","updated_at":"2024-07-02T16:36:00.277Z","phase":"Phase 2","brief_title":"Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway","source_id_and_acronym":"NCT02598895","lead_sponsor":"University of Washington","biomarkers":" BRCA1 • BRCA2 • BRIP1","pipe":" | ","alterations":" PALB2 mutation • BRIP1 mutation • BRCA2 biallelic inactivation","tags":["BRCA1 • BRCA2 • BRIP1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e PALB2 mutation • BRIP1 mutation • BRCA2 biallelic inactivation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • docetaxel"],"overall_status":"Completed","enrollment":" Enrollment 14","initiation":"Initiation: 01/26/2016","start_date":" 01/26/2016","primary_txt":" Primary completion: 09/14/2021","primary_completion_date":" 09/14/2021","study_txt":" Completion: 09/14/2021","study_completion_date":" 09/14/2021","last_update_posted":"2022-11-17"}]